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Coxsackievirus B4 (CBV4), a member of the Picornavirus genus, has long been implicated in the development of insulin-dependent
diabetes mellitus (IDDM), by viral-induced pancreatic cell damage. Although the pancreotropic nature of this virus is well documented, the
early stages of CBV4 viral infection that involve the attachment of virions to the cell surface by binding to their cellular receptors followed by
entry into the cell, are poorly understood. In this study, we show that the entry of CBV4 requires functional lipid rafts as the site of virus
attack. In addition, we show that this virus is endocytosed independently of clathrin-associated machinery and is delivered to the Golgi via a
lipid-raft-dependent mechanism.
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Insulin-dependent diabetes mellitus (IDDM), also known
as type I diabetes, is caused by progressive destruction of
pancreatic h cells. Epidemiological studies have shown that
Coxsackievirus infections are associated with the develop-
ment of type I diabetes (Banatlava, 1987; Horwitz, 1990;
Yoon et al., 1979). The most commonly detected strain in
diabetic and prediabetic patients is Coxsackievirus B4
(Horwitz, 1990). This virus infects several tissues, but
primarily it causes degenerate destruction of large regions
of exocrine pancreas as well as h islets leading to IDDM.
Although the pancreotropic nature of this virus is well
documented, very little is known about the pathways by
which this virus infects the pancreatic cells of the host.
Understanding the transport mechanism of CBV4 into
pancreatic cells is essential for successful development of
efficacious prophylactic and therapeutic measures.
Both the attachment and entry of any virus into a host
cell are dependent on the interaction of the virus with the
plasma membrane. Although the plasma membrane was
envisioned as a fluid randomly arranged lipid bilayer, recent0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.04.051
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barrier is more sophisticated. Several studies have shown
the existence of cholesterol-enriched microdomains that are
essential for cellular function (Damjanovitch et al., 1999;
Edidin, 2001; Jacobson and Dietrich, 1999; Jacobson et al.,
1995). Lipid rafts, or microdomains as they are also called,
appear as detergent/insoluble/resistant glycolipid-enriched
membrane domains and are believed to perform diverse
functions by providing a specialized microenvironment in
which the relevant molecules for the specific biological
processes are partitioned from the rest of the plasma
membrane and are concentrated into the raft (Horejsi et al.,
1999).
Such partitioning has been shown to play a role in a
plethora of biological functions such as signal transduction,
membrane transport, T cell activation, and host–pathogen
interactions (Romagnoli and Bron, 1997; Viola et al., 1999;
Xavier et al., 1998). Lipid rafts seem to play a role in the
internalization of bacterial lipopolysaccharide (Triantafilou
et al., 2002b) as well as budding of HIV (Lindwasser and
Resh, 2001; Nguyen and Hildreth, 2000; Ono and Freed,
2001) and influenza virus (Scheiffele et al., 1999), while the
involvement of rafts in their entry has also been postulated
(Dimitrov, 2000). Recent studies have also shown that
several enteroviruses including echovirus 1 (Marjomaki
et al., 2002), echovirus 11 (Stuart et al., 2002), as well as
Table 1
Energy transfer efficiency values between donor–acceptor pairs
Donor (Cy3) Acceptor (Cy5) E F DE (%)
Before virus infection
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utilize lipid rafts for cell entry.
In this study, we set out to determine the initial steps of
CBV4 infection of pancreatic cells, which include the
interaction of CBV4 with the plasma membrane as well as
subsequent internalization and transport within the cell.
There are several endocytic pathways that viruses utilize.
For example, Semliki Forest virus enters the cell through
clathrin-mediated endocytosis (Helenius et al., 1980), while
Simian virus 40, a simple nonenveloped DNA virus that
replicates in the nucleus, enters cells through caveolae
(Hummeler et al., 1970). After binding to the cell surface
via MHC class I molecules, SV40 moves laterally along the
plasma membrane until trapped in caveolae (Pelkmans et al.,
2001), whereas Echovirus 11 clusters the GPI-anchored
protein CD55 leading to lipid-raft-dependent internalization
(Stuart et al., 2002).
We investigated CBV4 interactions with its cellular
receptor Coxsackie Adenovirus receptor protein (CAR)
(Bergelson et al., 1997) as well as with CD55 which is
utilized by several Coxsackie B viruses (CBV1, CBV3,
CBV5) as a receptor molecule (Shafren et al., 1995) for
virus binding. Using fluorescent imaging techniques, we
followed the intracellular interactions of the virus. We found
that, initially, CBV4 is colocalized with CD55 and Cox-
sackie-adenovirus-receptor protein (CAR) within lipid rafts.
Subsequently, we found that CBV4 is internalized and
rapidly reaches the Golgi apparatus independently of cla-
thrin-interacting endocytic machinery. This transport path-
way appears to be raft specific, yet not all CBV4 receptors
follow it as there is a percentage of CAR visualized within
endosomes, thus suggesting that CAR can also follow the
clathrin endocytic machinery.
Overall, our data suggest that this virus takes advantage
of the considerable fluidity of lipid rafts between the
plasma membrane and the Golgi complex to gain access
to the cell. Our findings agree with Nichols et al. (2001c),
who have demonstrated a novel rapid recycling pathway
from the plasma membrane to the Golgi that is followed
by lipid raft markers. It seems that CBV4 attachment
induces the recruitment of CAR and CD55 into membrane
microdomains, and takes advantage of the internalization
of these domains to reach and accumulate in the Golgi
apparatus.
MHC-class I h2-m 39 F 1.7
Transferrin receptor Integrin avh3 2.0 F 1.5
CBV4-E2 GM1 ganglioside 19 F 1.0
CD55 GM1 ganglioside 23 F 0.5
CAR GM1 ganglioside 11 F 1.5
Transferrin receptor GM1 ganglioside 2.2 F 0.6
After CBV4-E2 infection
CD55 GM1 ganglioside 30 F 1.2
CAR GM1 ganglioside 29 F 0.5
Transferrin receptor GM1 ganglioside 2.6 F 0.8
Energy transfer between different pairs was detected from the increase in
donor fluorescence after acceptor photobleaching. Data represent mean F
standard deviation of three independent experiments.Results
Cell surface interactions of CBV4: FRET imaging of lipid
rafts
The concentration of CBV4 particles and receptor mol-
ecules involved in CBV4 attachment within lipid rafts was
examined using fluorescence resonance energy transfer
(FRET). Lipid rafts tend to aggregate into distinct patches
on the cell membrane that can be visualized by fluorescencemicroscopy using Cy5-conjugated cholera toxin, which
binds to GM-1 ganglioside, a raft-associated lipid.
We measured FRET in terms of dequenching of donor
fluorescence after complete photobleaching of the accep-
tor fluorophore. Increased donor fluorescence after com-
plete destruction of the acceptor indicated that the donor
fluorescence was quenched in the presence of the accep-
tor because of energy transfer. We tested the energy
transfer efficiency in our system using as a positive
control the energy transfer from MAbs Cy3–W6/32 and
Cy5-MCA1115 to two different epitopes on MHC-class I
molecules (Table 1), which showed that the maximum
energy transfer efficiency (E) was 39 F 1.7% (under
idealized FRET conditions, a maximum E of 40.96% is
achieved). A negative control involving irrelevant surface
receptors such as the transferrin receptor and integrin
avh3 was performed by testing the energy transfer
between Cy3-M073401 specific for the transferrin recep-
tor and Cy5-MCA757G specific for the integrin avh3,
the resulting E was 2 F 1.5%.
To visualize whether CBV4 viruses were localized in
lipid rafts, we measured FRET on pancreatic cells between
CBV4 particles (using Cy3-specific CBV4 Fab) and GM1
ganglioside, a raft-associated lipid (using Cy5-cholera tox-
in). Dequenching was observed once the Cy5 was photo-
bleached (E = 19 F 1.0%), suggesting that the virus
concentrates in the lipid rafts of the plasma membrane
(Fig. 1). Control experiments were performed with the
Cy5-cholera toxin using Cy3-specific CBV4 Fab without
the presence of CBV4 particles. The results showed that the
energy transfer efficiency was 1.8 F 0.5%, thus verifying
that there was no nonspecific interaction. We also tested the
association of transferrin receptor (Cy3-M073401), which is
a known nonraft marker with Cy5-cholera toxin for GM1-
ganglioside. Our data showed an energy transfer efficiency
of 2.2 F 0.6%, thus verifying that the transferrin receptor is
not concentrated in lipid rafts (Table 1).
Fig. 1. CBV4 and GM1 ganglioside FRET measurements. Energy transfer between CBV4 (Cy3-specific CBV4 Fab) and GM1 ganglioside (Cy5-Cholera toxin)
can be detected by the increase in donor fluorescence after acceptor photobleaching. Donor (Cy3) after acceptor photobleaching (A) and (B) E image. E as a
function of the fluorescence at donor/acceptor antibody ratios of 1:1 (white squares), 1:2 (black squares), and 1:4 (triangles) (C). Scale bar = 5Am.
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localize in lipid rafts before CBV4 infection, by using Cy3-
MCA914 Fab specific for CD55 and Cy3–C1079 specific
for CAR protein, respectively, and Cy5-cholera toxin for the
GM1 ganglioside. Our results showed that there was FRET
observed between CD55 and GM1 ganglioside (23F 0.5%);
thus, CD55 was present in lipid rafts before CBV4 infection.
On the other hand, there was a small percentage of CAR
protein associating with lipid rafts, giving FRET values of
11 F 1.5% (Table 1).
We then examined whether CD55 or CAR molecules
were recruited into the raft after infection with CBV4. FRET
experiments were therefore performed with CD55 and GM1
ganglioside as well as CAR protein and GM1 ganglioside in
the presence of CBV4 particles. We found that there was an
increased association between CD55 (Cy3-MCA914 Fab)
and GM1 ganglioside (Cy5-cholera toxin) (E = 30 F 1.2%)
as well as CAR and GM1 ganglioside (E = 29 F 0.5%) in
the presence of CBV4 particles (see Table 1). Our data show
that upon virus infection, although CD55 is localized in
lipid rafts (which is expected as it is a GPI linked protein),there is a significant increase of CD55 molecules in the lipid
rafts after virus infection. There is also a significant increase
of CAR molecules recruited in the raft upon CBV4 infec-
tion. However, after virus infection, there was no association
between trasferrin receptor and GM1-ganglioside (E = 2.6F
0.8%). To rule out the possibility that the FRET observed
was due to random distribution, we varied the ratio of
donors and acceptors used to label the proteins of interest
(Fig. 1). E was found to be independent on acceptor density,
to be sensitive to donor/acceptor ratio, and not to go to zero
at low surface density, thus suggesting that the FRET values
observed were due to clustered molecules and not random
associations.
Entry route
To investigate the entry route of CBV4 into pancreatic
cells, we used vital stains for known vesicular compartments
in pancreatic cells as well as fluorescent probes for CBV4
(using a Cy5-specific CBV4 Fab), CD55 (TRITC-MCA914
Fab), and CAR (TRITC-C1079).
filou /CBV4 does not concentrate in lysosomes
Lysosomes are acidic vesicles rich in hydrolytic enzymes
and represent the site of degradation of extracellular macro-
molecules internalized by pinocytosis or phagocytosis. We
determined if CBV4 or its receptors CD55, CAR are
internalized into lysosomes using a green fluorescent, freely
permeant probe with a high selectivity for acidic organelles,
Lysotraker Green DND-99 (Loike et al., 1991). Pancreatic
cells were incubated for different time periods (5, 15, 30,
and 60 min) with CBV4 particles in the presence of
Lysotraker Green DND-99. Triple labeling with Lysotraker
Green DND-99, CBV4-specific probe, and CD55-specific
probe (TRITC-MCA914 Fab) or CAR-specific probe
(TRITC-C1079) was performed. Our results showed that
CAR was internalized within lysosomes, while CD55 did
not colocalize within lysosomes. The compartment contain-
ing internalized CBV4 was readily distinguishable from
lysosomes (Fig. 2). Overall, these results suggest that
although lysosomes handle the endocytosis of CAR recep-
tors, the vesicular transport of CBV4 from the plasma
membrane does not appear to deliver the virus particles to
lysosomes.
K. Triantafilou, M. TriantaFig. 2. Intracellular distribution of CBV4, CAR, or CD55 and organelle marker for l
CBV4 Fab are seen as blue. Lysosomes are labeled green with Lysotraker green D
labeled with TRITC-MCA914 are seen as red. A merged image of the three (CBV4
CD55, lysosomes). Although CBV4 and CD55 do not overlap with the labeling pat
as yellow). Scale bar = 5 Am. (For interpretation of the references to colour in thiCBV4 does not concentrate in endosomes
Endosomes are a structurally diverse population of
vacuoles and tubules serving as sorting intermediates along
both the biosynthetic and endocytic pathways. To deter-
mine the CBV4 endocytic pathway, we used a FITC-
conjugated EEA1-specific serum to label early endosomes
because EEA1 is an early endosome marker. Triple label-
ing in pancreatic cells with EEA1-specific serum conju-
gated to FITC (FITC-anti EEA1), CBV4, and CD55 or
CAR-specific fluorescent probes at 5, 15, 30, and 60 min
postinfection showed no colocalization between the virus
and EEA1 or CD55 and EEA1, suggesting that the virus
does not enter early endosomes (Fig. 3). However, there
was some degree of colocalization between CAR and
EEA1 (Fig. 4).
Fluorescent dextran, a hydrophylic polysaccharide with
poly-(a-D-1,6-Glucose) linkages, is rapidly taken up by an
endocytic process and moves to early and late endosomes
(Berlin and Oliver, 2003). We studied the internalization of
a fluid-phase marker (FITC-dextran) CBV4 and CD55 or
CAR in pancreatic cells. At 30 min p.i., FITC–dextran
appeared in a heterogeneous assortment of internalized
Virology 326 (2004) 6–19 9ysosomes at 30-min postinfection. CBV4 particles labeled with Cy5-specific
ND-99. CAR molecules labeled with TRITC-C1079 and CD55 molecules
, CAR, lysosomes) is shown as well as a merged image of the three (CBV4,
tern of lysosomes, there is colocalization between CAR and lysosomes (seen
s figure legend, the reader is referred to the web version of this article.)
Fig. 3. Intracellular distribution of CBV4, CD55, and FITC-conjugated anti-EEA1-specific serum (FITC anti EEA1) for the detection of early endosomes at
30-min postinfection is shown. CBV4 particles labeled with Cy5-specific CBV4 Fab are seen as blue. Endosomes are revealed as green with FITC-anti EEA1.
CD55 molecules labeled with TRITC-MCA914 are seen as red. Intracellular distribution of CBV4, CD55, and FITC anti-EEA1 at 15-min postinfection in the
presence of NH4Cl (50 nM) is also shown. A merged image of the three (CBV4, CD55, early endosomes) is also shown. Scale bar = 5 Am. (For interpretation
of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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from FITC–dextran, showing us that the virus does not
localize in late endosomes. Neither was CD55, while there
was partial colocalization of CAR with dextran as man-
ifested by the punctate yellow staining in the merged
images (Fig. 5).
Inhibition of acidification of endosomes
Virions internalized by endocytosis penetrate the cyto-
plasm by fusing with membranes of endosomes or lyso-
somes in a pH-independent or -dependent manner. Viruses
such as Semliki forest virus (Garoff et al., 1994), Influenza
virus (March and Pelschen-Mathews, 2000), and Human
Herpesvirus 8 (Akula et al., 2003) require exposure to low
pH environment to enter endosomes, while viruses such as
duck hepatitis virus enter via pH-independent endocytosis
(March and Pelschen-Mathews, 2000). Although we had
already seen that CBV4 does not penetrate lysosomes or
endosomes, we decided to examine whether a change in pH
could affect the virus entry mechanism. We used NH4Cl,
which is a weak lysosomotropic base that diffuses into
acidic endosomes, where it becomes protonated. Once
protonated, it is unable to diffuse out, thus increasing the
pH. The cells were treated with 25 or 50 nM NH4Cl; theearly endosomes were stained with FITC-EEA1-specific
serum and we looked at the distribution of CBV4, CAR,
or CD55. Our results showed that there was no change in
the virus or the CD55 distribution (Fig. 3) while NH4Cl
inhibited CAR entry in early endosomes (Fig. 4).
CBV4 does not concentrate in the ER
Endoplasmic reticulum is the largest endomembrane
system within eukaryotic cells and performs a wide
variety of functions, including calcium uptake and re-
lease, lipid and protein synthesis, protein translocation
and folding, glycosylation, concentration and export to
the Golgi complex. We used anticalnexin antibody con-
jugated to FITC (FITC anticalnexin) to label the ER. The
infected cells showed no accumulation of virus in the
ER. Fluorescent virus was observed in vesicular struc-
tures distinct from the ER (Fig. 6).
CBV4 concentrates in the Golgi
To determine whether CBV4 was localized in the
Golgi, we used two different markers to label compart-
ments of the Golgi apparatus. Anti-TGN38-specific anti-
body conjugated to FITC to label the TGN-38 integral
Fig. 4. Intracellular distribution of CBV4, CAR, and FITC-conjugated anti-EEA1-specific serum (FITC anti EEA1) for the detection of early endosomes at 30-
min postinfection is shown. CBV4 particles labeled with Cy5-specific CBV4 Fab are seen as blue. Endosomes are revealed as green with FITC–anti-EEA1.
CAR molecules labeled with TRITC-C1079 are seen as red. Although CBV4 does not overlap with the labeling pattern of endosomes, there is colocalization
between CAR and endosomes (seen as yellow). Intracellular distribution of CBV4, CAR, and FITC anti EEA1 at 15-min postinfection in the presence of
NH4Cl (50 nM) is also shown. A merged image of the three (CBV4, CAR, early endosomes) is also shown. Scale bar = 5 Am. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web version of this article.)
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Banting, 1999) and the anti GM130 specific antibody to
a cis-Golgi matrix protein of the cis-Golgi apparatus
structure, which we had conjugated to FITC. Triple
labeling in pancreatic cells with FITC-labeled anti-TGN-
38 or FITC–anti GM130, CBV4, and CD55 or CAR-
specific fluorescent probes at 15, 30, and 60 min p.i.
showed colocalization of the virus, CAR, and CD55 with
GM130 after 30 to 60 min p.i. (Figs. 7 and 8). No
colocalization of CBV4, CD55, or CAR with TGN38
was observed (data not shown), suggesting that the virus
and its receptors are mainly concentrated in the cis-Golgi
and not the trans-Golgi network.
Effects of clathrin route inhibitors on CBV4 entry
To determine whether CBV4 utilizes clathrin-coated pits
for internalization, we used different clathrin inhibitors
before CBV4 infection. We utilized various chemicals that
we had tested and were not cytotoxic to the cells, such as
nocodazole (20 AM) and chloropromazine (25 AM). Noco-
dazole is known to block endosomal traffic between earlyand late endosomes (Gruenberg et al., 1989), whereas
chloropromazine causes the disappearance of clathrin-coat-
ed pits from the cell membrane (Joki-Korpela et al., 2001;
Wang et al., 1993).
Nocodazole or chloropromazine did not prevent the
efficiency of viral replication, which was analyzed by
counting the number of virus-infected immunofluores-
cence-positive cells (Table 2). Using triple fluorescent
labeling, we investigated the concentration of CBV4 as well
as CAR and CD55 in the Golgi apparatus after treatment
with either of the two chemicals. We found that neither
nocodazole nor chloropromazine prevented the localization
of CBV4 and CD55 with the Golgi, nor CBV4 infectivity
(Fig. 9). In contrast, both chemicals seem to affect (Fig. 10)
but not completely inhibit the localization of CAR. Overall,
this data show that virus entry into pancreatic cell is clathrin
independent.
Effects of raft-disrupting drugs on CBV4 entry
Because we had already found that CBV4 and its receptor
molecules localize in lipid rafts in the initial steps of virus
Fig. 5. Intracellular distribution of CBV4, CAR, or CD55 and organelle marker for endosomes. CBV4 particles labeled with Cy5-specific CBV4 Fab are seen as
blue. Endosomes are revealed as green with FITC–Dextran. CARmolecules labeled with TRITC-C1079 and CD55 molecules labeled with TRITC-MCA914 are
seen as red. A merged image of the three (CBV4, CAR, endosomes) and (CBV4, CD55, endosomes) is shown. Although CBV4 particles do not overlap with the
labeling pattern of endosomes, there is a partial overlap between CAR and endosomes, which is seen as yellow. Scale bar = 5 Am. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web version of this article.)
K. Triantafilou, M. Triantafilou / Virology 326 (2004) 6–1912attachment, we investigated whether lipid raft-disrupting
drugs such as nystatin (Anderson et al., 1996) or filipin
(Keller and Simons, 1998), which had been tested and were
not cytotoxic at the optimal concentrations of 25 AM and 1
Ag/ml, respectively, could inhibit viral entry. Using confocal
microscopy, we counted the virus-infected immunofluores-
cence-positive cells (see Materials and methods). Our resultsFig. 6. Intracellular distribution of CBV4, CAR, and anticalnexin antibody conjuga
particles labeled with Cy5-specific CBV4 Fab are seen as blue. ER is seen as gree
seen as red. A merged image of the three is also shown. Scale bar = 5 Am. (For
referred to the web version of this article.)showed that cells pretreated with nystatin or filipin showed
inhibition of virus infection (Table 2), while fluorescent
labeling revealed that treatment with either filipin (data not
shown) or nystatin prevented CBV4 colocalization to the
Golgi (Figs. 9 and 10), leading us to believe that CBV4 viral
entry and targeting to the Golgi apparatus is dependent on
lipid raft integrity. The cells’ viability was not affected eitherted to FITC (FITC anticalnexin) to label ER at 60-min postinfection. CBV4
n with FITC anti calnexin. CAR molecules labeled with TRITC-C1079 are
interpretation of the references to colour in this figure legend, the reader is
Fig. 7. Intracellular distribution of CBV4, CD55, and FITC–anti-GM130 for cis-Golgi at 0, 15, 30, and 60 min postinfection is shown. CBV4 particles labeled
with Cy5-specific CBV4 Fab are seen as blue. cis-Golgi is seen as green. CD55 molecules labeled with TRITC-MCA914 are seen as red. Merged images of the
three are also shown (CBV4, Golgi, CD55), which show that CD55 and CBV4 concentrate in the cis-Golgi (colocalization of all three; CBV4, Golgi, CD55 is seen
as white) at 30 and 60 min. Scale bar = 5 Am. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this
article.)
K. Triantafilou, M. Triantafilou / Virology 326 (2004) 6–19 13by nystatin or filipin treatment as the drug-treated cells
excluded trypan blue.Discussion
For pancreatic cells to be infected by CBV4, the virus has
to first attach to the cell surface using specific receptors,
such as CAR (Bergelson et al., 1997), subsequently pene-
trate the plasma membrane, and traffic through the cell totarget its RNA to the nucleus. In this study, we investigated
the attachment as well as the entry route of CBV4 in
pancreatic cells.
Initially, we looked at the distribution on the plasma
membrane of CBV4 virions, CAR (Bergelson et al., 1997),
the main Coxsackievirus B receptor, as well as CD55, which
is a protein utilized by several Coxsackieviruses for binding
(Shafren et al., 1995).
Using FRET, we found that CBV4 virus particles as well
as both CAR and CD55 are concentrated within lipid rafts
Fig. 8. Intracellular distribution of CBV4, CAR, and FITC–anti-GM130 for cis-Golgi at 0, 15, 30, and 60-min postinfection is shown. CBV4 particles labeled
with Cy5-specific CBV4 Fab are seen as blue. cis-Golgi is seen as green. CAR molecules labeled with TRITC-C1079 are seen as red. Merged images of the
three are also shown (CBV4, Golgi, CAR), which show that CAR and CBV4 concentrate in the cis-Golgi (colocalization of all three; CBV4, Golgi, CAR is
seen as white) at 30 and 60 min. Scale bar = 5 Am. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of
this article.)
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CBV4 infectious cycle. CD55, which is a GPI-linked
protein, seems to be constitutively localized in lipid rafts,
whereas CAR although present in a smaller percentage than
CD55 in the raft, was shown to increasingly accumulate in
the raft upon the presence of CBV4 virions.
Following the attachment of the virus, we attempted to
track the entry route of the virus within the cell. Several
nonenveloped viruses have been shown to use the clathrin-
endocytic machinery to gain access into the cells. Exam-ples of such viruses include canine parvovirus, adenovirus,
parechovirus 1, rhinovirus 14, as well as polyomaviruses
(DeTulleo and Kirchhausen, 1998; Joki-Korpela et al.,
2001; Pho et al., 2000). Other viruses, such as Simian
virus 40, which binds to MHC-class I, utilizes caveolar
endocytosis (Hummeler et al., 1970).
To elucidate CBV4 entry, we utilized triple-labeling
fluorescent imaging to visualize CBV4, CAR, or CD55,
with markers for different intracellular compartments. We
found that CBV4 did not colocalize with lysosomes, endo-
Table 2
Percentage of CBV4 infected PANC-1 cells (2 h p.i.) in cells treated with
different drug inhibitors
% Infectivity % Toxicity
Chloropromazine (AM)
0 72.5 0.5
25 66.9 5.0
Nocodazole (AM)
0 70.3 0.8
20 67.5 5.2
Nystatin (AM)
0 71.8 0.6
25 13.2 5.2
Filipin (Ag)
0 70.7 0.8
1 11.8 3.5
Toxicity was determined by trypan blue staining. This table represents data
from three independent experiments.
K. Triantafilou, M. Triantafilou / Virology 326 (2004) 6–19 15somes, or ER over different time periods (0, 15, 30, or 60
min p.i.). In contrast, it was found that CBV4 was rapidly
targeted to the Golgi apparatus and specifically to the cis-
Golgi network 30–60 min p.i.
In previous studies it has been shown that CD55 is not
necessary for virus entry (Shafren et al., 1995), but sinceFig. 9. Intracellular distribution of CBV4, CD55, and FITC–anti-GM130 for c
nystatin. CBV4 particles labeled with Cy5-specific CBV4 Fab are seen as blue. Go
as red. A merged image of the three is also shown. Colocalization of all three: CBV
references to colour in this figure legend, the reader is referred to the web versioCD55 is a GPI-linked protein and thus constitutively resides
in the lipid raft, it targets the Golgi through a clathrin-
independent route, similar to CBV4.
On the other hand, although CAR, a transmembrane pro-
tein, is localized in lipid rafts, it seems to be able to follow a
clathrin-dependent route, as we have visualized CAR in
lysosomes and endosomes. However, to a smaller percentage,
it also follows a clathrin-independent route, because it cannot
be completely inhibited in all cells by anticlathrin inhibitors,
thus demonstrating the capability of this protein to use both
routes, which could explain why adenovirus, which uses CAR
as its main receptor, has the ability to enter cells via two
different endocytic processes (Asbourne Excoffon et al., 2003).
In an attempt to verify whether CBV4 entry was
dependent on clathrin-coated pits, we utilized different
clathrin inhibitors before incubation with CBV4 virions.
Chemicals such as nocodazole and chloropromazine,
which are known to block endosomal traffic between early
and late endosomes (Gruenberg et al., 1989), and to cause
the disappearance of clathrin-coated pits from the cell
membrane (Wang et al., 1993), respectively, were also
utilized. These chemicals did not inhibit CBV4 internali-
zation. Furthermore, using triple labeling, we visualizedis-Golgi at 60-min postinfection in the presence of chloropromazine and
lgi is seen as green. CD55 molecules labeled with TRITC-MCA914 are seen
4, Golgi, CD55 is seen as white. Scale bar = 5 Am. (For interpretation of the
n of this article.)
Fig. 10. Intracellular distribution of CBV4, CAR and FITC–anti-GM130 for cis-Golgi at 60-min postinfection in the presence of nocodazole and nystatin.
CBV4 particles labeled with Cy5- specific CBV4 Fab are seen as blue. Golgi is seen as green. CAR molecules labeled with TRITC-C1079 are seen as red. A
merged image of the three is also shown. Colocalization of all three; CBV4, Golgi, CAR is seen as white. Scale bar = 5 Am. (For interpretation of the references
to colour in this figure legend, the reader is referred to the web version of this article.)
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preincubation with the clathrin-route inhibitors did not
affect CBV4 infection of pancreatic cells, thus suggesting
that CBV4 gains entrance and is targeted to the cis-Golgi
via a clathrin-independent route.
In addition, CBV4 internalization seemed to be lipid
raft dependent. In the presence of lipid-raft-disrupting
drugs, such as nystatin or filipin, CBV4 infectivity was
inhibited. Furthermore, targeting of CBV4 to the Golgi
network was inhibited upon disruption of the lipid raft
integrity. Our studies suggest that lipid raft formation is
crucial for CBV4 entry and trafficking through the pan-
creatic cell.
Previous observations have shown that the entire choles-
terol, ganglioside-rich microdomain or ‘‘lipid raft’’, where
we have shown that CBV4, CAR, and CD55 reside, is
constantly shuttling back and forth from the cell surface to
the Golgi (Nichols et al., 2001a; Vishwajeet et al., 2001).
Our studies confirm this because when we incubated pan-
creatic cells with Cy3-labeled cholera toxin, which binds to
GM-1 ganglioside (a lipid raft marker), the cholera toxinwas rapidly targeted from the cell surface to the Golgi
apparatus indistinguishably of CBV4, CD55, and CAR
(data not shown).
Our data suggests that CBV4 is dragged to the Golgi
along with the lipid raft and a small percentage of CAR
via a novel clathrin-independent endocytic route. CBV4
seems to have evolved to take advantage of the plasma
membrane–Golgi cycling pathway that is followed by
sphingolipids, which make up lipid rafts. By following
this route, CBV4 gains rapid entrance into the pancreatic
cell and reaches its biosynthetic machinery within only
30–60 min p.i. Like Echovirus 1 (Marjomaki et al., 2002),
Echovirus 11(Stuart et al., 2002), and Coxsackievirus A9
(Triantafilou and Triantafilou, 2003), CBV4 has been
shown to utilize lipid rafts for cell entry. The pathway
that viruses follow upon internalization seems to be
dictated by the receptor or the receptor complexes that
the virus utilizes. Thus, other viruses that utilize molecules,
which reside in lipid rafts, may also follow this rapid
internalization pathway from the plasma membrane to the
Golgi apparatus.
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Cell lines
Human pancreatic cell line (PANC-1) was maintained in
DMEM with Glutamax and 4500 mg/l glucose medium
(Gibco) containing 10% heat-inactivated fetal bovine serum.
Human pancreatic cell line (ASPC-1) was maintained
in RPMI with Glutamax (Gibco) containing 10% heat-
inactivated fetal bovine serum.
Viruses
The diabetogenic strain, CBV4 Edwards strain 2 (E2),
was kindly provided by Dr. J.W. Yoon (Yoon et al.,
1979). The virus was propagated in PANC-1 cells. For
immunofluorescence experiments, viruses were used at an
MOI of 10.
Materials
CD55-specific mAb MCA914 was obtained from Sero-
tec (U.K.). RcmB CAR-specific mAb for initial experiments
was kindly provided by Dr. Bergelson, while CAR-specific
mAb C1079 was obtained from Europa Bioproducts. Horse
polyclonal serum specific for CBV4 was purchased from
American Tissue Type Collection (ATTC). Lysotraker
Green DND-99, DiOC6, FITC-Dextran, FITC-Con A,
NBDC6 ceramide were obtained from Molecular Probes
Inc. EEA1-specific goat polyclonal serum and Calnexin-
specific rabbit serum were obtained from Santa Cruz Bio-
technology (CA). Mouse anti-GM130 was purchased from
Transduction Labs/BD PharMingen (San Diego, CA).
Mouse anti-TGN38 was from Affinity Bioreagents (Golden,
CO). The antibodies were conjugated to either Cy3 or Cy5
(using Cy3 and Cy5 labeling kits from Amersham-Pharma-
cia), or they were conjugated to either FITC or TRITC
(Molecular Probes Inc.) according to the manufacturers’
instructions. Cholera toxin was purchased from List Labs.
The following chemicals were obtained from Sigma and
used to study the viral entry procedures: nocodazole (20
AM) for depolymerization of microtubules; chloropromazine
(25 and 50 AM) to inhibit the formation of clathrin coated
pits; nystatin (25 AM) and filipin (1 Ag/ml) for the disruption
of rafts; and NH4Cl (25 and 50 nM), a weak base, to inhibit
low-pH-dependent endosomal fusion.
Cell labeling for FRET
PANC-1 or ASPC-1 cells on microchamber culture slides
(Lab-tek, Gibco) were labeled with 100 Al of a mixture of
donor-conjugated antibody Cy3) and acceptor-conjugated
antibody Cy5. The cells were rinsed twice in PBS/0.02%
BSA, before fixation with 4% formaldehyde for 15 min. The
cells were fixed to prevent potential reorganization of the
proteins during the experiment.Confocal imaging
PANC-1 or ASPC-1 cells were grown on microchamber
culture slides. Cells were infected with CBV4-E2; after
different times postinfection (p.i), they were exposed to
fluorescent stains for organelles (these experiments were
done by binding the virus to cells at low temperatures
followed by a shift to 37 jC) and subsequently fixed with
4% formaldehyde for 15 min. For virus and receptor
staining, fluorescent probes were added and incubated for
60 min in PBS/0.02% BSA/0.02% Saponin, then washed
three times with PBS. The slides were mounted on Prolong
antifade (Molecular Probes).
When specific inhibitory drugs were used, the chemicals
(nocodazole, chloropromazine, nystatin, filipin) were added
to the cell culture medium before attachment of the virus for
30 min and they were also present during infection. The
efficiency of viral replication was analyzed by counting the
number of immunofluorescence-positive cells by confocal
microscopy after 1, 2, 4, and 6 h. Cells were imaged on a
Carl Zeiss, Inc. LSM510 META confocal microscope (with
an Axiovert 200 fluorescent microscope) using a 1.4 NA
63 Zeiss objective. The images were analyzed using LSM
2.5 image analysis software (Carl Zeiss, Inc.). FITC and
TRITC were detected using the appropriate filter sets. Using
typical exposure times for image acquisition (less than 5 s),
no fluorescence was observed from a FITC-labeled speci-
men using the TRITC filters, nor was FITC fluorescence
detected using the TRITC filter sets.
FRET measurements
FRET is a noninvasive imaging technique used to deter-
mine molecular proximity. FRET can occur over 1–10-nm
distances, and effectively increases the resolution of light
microscopy to the molecular level. It involves nonradiative
transfer of energy from the excited state of a donor molecule
to an appropriate acceptor. The rate of energy transfer is
inversely proportional to the sixth power of the distance,
between donor and acceptor. The efficiency of energy
transfer (E) is defined with respect to r and R0, the
characteristic Forster distance by:
E ¼ 1=½1þ ðr=R0Þ6 ð1Þ
In the present study, FRET was measured using a previ-
ously described method (Bastiaens and Jovin, 1996; Nich-
ols et al., 2001b; Triantafilou et al., 2002a). Briefly,
samples were labeled with donor- and acceptor-conjugated
antibodies and energy transfer was detected as an increase
in donor fluorescence (dequenching) after complete photo-
bleaching of the acceptor molecule. Cy5 was bleached
by continuous excitation with an arc lamp using a Cy5
filter. FRET images were calculated from the increase in
donor fluorescence after acceptor photobleaching by E
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